Calogero Cammà

20.2k total citations · 2 hit papers
271 papers, 12.0k citations indexed

About

Calogero Cammà is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Calogero Cammà has authored 271 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Epidemiology, 182 papers in Hepatology and 41 papers in Surgery. Recurrent topics in Calogero Cammà's work include Liver Disease Diagnosis and Treatment (175 papers), Hepatitis C virus research (105 papers) and Hepatocellular Carcinoma Treatment and Prognosis (53 papers). Calogero Cammà is often cited by papers focused on Liver Disease Diagnosis and Treatment (175 papers), Hepatitis C virus research (105 papers) and Hepatocellular Carcinoma Treatment and Prognosis (53 papers). Calogero Cammà collaborates with scholars based in Italy, United States and France. Calogero Cammà's co-authors include Antonio Craxı̀, V. Di Marco, Salvatore Petta, Mario Cottone, Marco Giunta, Daniela Cabibi, Marco Enea, Giuseppe Cabibbo, Anna Licata and Pietro Andreoné and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Calogero Cammà

259 papers receiving 11.7k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Meta-Analysis of Randomized Controlled Trials

2002 650 citations Calogero Cammà, Pietro Andreoné et al. profile →
Preoperative Radiotherapy for Resectable Rectal Cancer

2000 566 citations Calogero Cammà, Antonio Craxı̀ et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Calogero Cammà Italy	62	8.4k	7.5k	2.3k	1.3k	1.2k	271	12.0k
Andrew D. Clouston Australia	57	4.9k 0.6×	3.8k 0.5×	2.7k 1.2×	2.4k 1.8×	1.3k 1.1×	197	11.4k
Markus Peck‐Radosavljevic Austria	66	8.4k 1.0×	9.7k 1.3×	3.1k 1.4×	1.8k 1.4×	1.5k 1.3×	376	14.7k
Geum‐Youn Gwak South Korea	44	4.9k 0.6×	4.8k 0.6×	1.7k 0.7×	1.3k 1.0×	736 0.6×	219	8.6k
Mario Rizzetto Italy	43	9.0k 1.1×	6.7k 0.9×	1.6k 0.7×	385 0.3×	667 0.6×	148	10.9k
Gregory T. Everson United States	63	8.6k 1.0×	10.1k 1.3×	3.8k 1.6×	1.1k 0.8×	497 0.4×	264	14.4k
Graeme Alexander United Kingdom	49	7.2k 0.9×	7.2k 1.0×	1.6k 0.7×	711 0.5×	395 0.3×	191	11.9k
Antoine Hadengue Switzerland	52	5.1k 0.6×	6.1k 0.8×	4.0k 1.7×	803 0.6×	732 0.6×	227	9.3k
Paul Calès France	55	9.0k 1.1×	7.7k 1.0×	2.4k 1.1×	400 0.3×	518 0.4×	305	11.5k
Ricard Solà Spain	31	6.7k 0.8×	7.8k 1.0×	1.8k 0.8×	639 0.5×	807 0.7×	75	9.8k
Hari S. Conjeevaram United States	36	7.8k 0.9×	6.9k 0.9×	1.0k 0.5×	485 0.4×	577 0.5×	84	9.7k

Countries citing papers authored by Calogero Cammà

Since Specialization

Citations

This map shows the geographic impact of Calogero Cammà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Calogero Cammà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Calogero Cammà more than expected).

Fields of papers citing papers by Calogero Cammà

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Calogero Cammà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Calogero Cammà. The network helps show where Calogero Cammà may publish in the future.

Co-authorship network of co-authors of Calogero Cammà

This figure shows the co-authorship network connecting the top 25 collaborators of Calogero Cammà. A scholar is included among the top collaborators of Calogero Cammà based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Calogero Cammà. Calogero Cammà is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pennisi, Grazia, Marco Enea, Ciro Celsa, et al.. (2025). A Markov Model Unveiling the Impact of Resmetirom on the Natural History of MASLD Patients: A Sistematic Review and Meta‐Analysis. Liver International. 45(4). e70056–e70056. 1 indexed citations

Celsa, Ciro, Grazia Pennisi, David J. Pinato, et al.. (2025). Glucagon-like peptide-1 receptor agonist use is associated with a lower risk of major adverse liver-related outcomes: a meta-analysis of observational cohort studies. Gut. 74(5). 815–824. 7 indexed citations

Celsa, Ciro, Pasquale Lombardi, Antonio D’Alessio, et al.. (2025). Integrating Quality of Life and Survival in Systemic Therapy for Advanced Hepatocellular Carcinoma. JAMA Oncology. 11(10). 1160–1160.

Celsa, Ciro, Giacomo Emanuele Maria Rizzo, Marco Enea, et al.. (2024). What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg‐negative anti‐HBc‐positive patients? Meta‐analysis and decision curve analysis. Liver International. 44(11). 2890–2903. 1 indexed citations

Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2024). Early Hepatic Decompensation Identifies Patients with Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab or Sorafenib at Highest Risk of Death. Clinical Cancer Research. 31(3). 543–550. 6 indexed citations

Dell’Anna, Giuseppe, Matteo Tacelli, Lívia Archibugi, et al.. (2024). Correlation between endoscopic ultrasound features and exocrine pancreatic function in chronic pancreatitis. Pancreatology. 24(6). 834–839.

Pons, Mònica, Jesús Rivera‐Esteban, Mang Ma, et al.. (2023). Point-of-Care Noninvasive Prediction of Liver-Related Events in Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 22(8). 1637–1645.e9. 27 indexed citations

Pennisi, Grazia, Ciro Celsa, Marco Enea, et al.. (2022). Effect of pharmacological interventions and placebo on liver Histology in nonalcoholic steatohepatitis: A network meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 32(10). 2279–2288. 17 indexed citations

Celsa, Ciro, Federica Spatola, Giacomo Emanuele Maria Rizzo, et al.. (2021). Systemic therapies for hepatocellular carcinoma: the present and the future. Recenti Progressi in Medicina. 112(2). 110–116. 4 indexed citations

10.

Maida, Marcello & Calogero Cammà. (2021). Young gastrointestinal angle: E‐learning in gastroenterology: Future is now. United European Gastroenterology Journal. 9(5). 635–637. 2 indexed citations

11.

Cabibbo, Giuseppe, Ciro Celsa, Marco Enea, et al.. (2020). Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma. Cancers. 13(1). 90–90. 20 indexed citations

12.

Tacelli, Matteo, Ciro Celsa, Bianca Magro, et al.. (2020). Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐analysis. Digestive Endoscopy. 32(7). 1018–1030. 57 indexed citations

13.

Petta, Salvatore, Francesca Rini, Vincenza Calvaruso, et al.. (2019). Aminopyrine breath test predicts liver‐related events and death in HCV‐related cirrhosis on SVR after DAA therapy. Liver International. 40(3). 530–538. 1 indexed citations

14.

Cabibbo, Giuseppe, M. Rossi, Ciro Celsa, Marcello Maida, & Calogero Cammà. (2018). Direct-acting antiviral agents and risk of hepatocellular carcinoma: is it still a clinical dilemma?. Recenti Progressi in Medicina. 109(12). 605–608. 1 indexed citations

15.

Rosso, Chiara, Salvatore Petta, M. Marietti, et al.. (2016). The combination of Index of NASH score and liver stiffness improves the noninvasive diagnostic accuracy for severe liver fibrosis in patients with NonAlcoholic Fatty Liver Disease.. Hepatology. 64. 578–578. 1 indexed citations

16.

Mancuso, Andrea, Alessandra Mazzola, Giuseppe Cabibbo, et al.. (2015). Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis. Digestive and Liver Disease. 47(4). 324–330. 46 indexed citations

17.

Cabibi, Daniela, Giuseppe Cabibbo, Calogero Cammà, et al.. (2014). Steatosis affects the performance of liver stiffness measurement for fibrosis assessment in patients with genotype 1 chronic hepatitis C. Default journal. 61. 523–529. 2 indexed citations

18.

Tomasello, Giovanni, Emanuele Sinagra, Dario Raimondo, et al.. (2014). The complex interplay between vitamin D deficiency and diabetes. Progress in nutrition. 17(1). 3–14. 1 indexed citations

19.

Conti, Fabio, Mario Luca Morieri, Annagiulia Gramenzi, et al.. (2009). 603 A MULTICENTER ITALIAN CROSS-SECTIONAL STUDY IN ELDERLY PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION. Journal of Hepatology. 50. S222–S222. 1 indexed citations

20.

Bortolotti, Flavia, Gabriella Verucchi, Calogero Cammà, et al.. (2008). Long-Term Course of Chronic Hepatitis C in Children: From Viral Clearance to End-Stage Liver Disease. Gastroenterology. 134(7). 1900–1907. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact